Current AD research focuses on understanding pathology by targeting several mechanisms, such as abnormal tau protein metabolism, -amyloid, inflammatory response, and cholinergic and free radical damage, aiming to develop successful treatments that are capable of stopping or modifying the course of AD (Tamagno et al., 2021)
For this reason, ongoing monitoring is important
FAQ Wegovy, Zepbound, Saxenda, and Foundayo are approved to treat adults with a BMI of 30 or greater, or with a BMI of at least 27 and one weight-related condition, such as high blood pressure or high cholesterol
The GHK tripeptide acts as a specific carrier designed to transport copper ions across biological membranes
Research indicates that oxytocin nasal spray may enhance various aspects of social cognition, such as eye contact, recognition of social cues, and empathy
Supporting the immune system by increasing immunoglobulins